Free Newsletter
Study: Top drug websites confusing, unbalanced
Top drug websites are like Alice in Wonderland's rabbit hole, a new analysis finds, you never know where they might take you. Two academic researchers took a look at the websites of the 100 best-selling drugs and found a navigational "maze" and a confusing mix of information and marketing.
What's more, these top drug sites often delivered information on safety and risks "in small font, in cumbersome un-bulleted blocks of text, detached from promotional text and videos and below a page's scrolling 'fold'." Under FDA principles--marked by the agency's recent moves on safety info in TV ads--that's a big no-no.
We also know that the agency is gathering info and comment for new regulations governing online promotions. To these researchers, rules for websites could only be a good thing. "The FDA has rules about direct-to-consumer print and television drug advertising," Dartmouth Linguistics Professor Lewis Glinert said, "so we think it makes sense to also regulate websites and other marketing tools when it comes to prescription medicine."
- read the Dartmouth release
- get more from United Press International
Related Articles:
PhRMA pitches solution to online ad woes
Fearing FDA, pharma abandons search ads
Big Pharma grows online, slowly
Online ad compliance isn't easy, pharma says
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: